[1] Kopp A F, Mortele K J, Cho Y D,et al.Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients[J].ActaRadiol, 2008,49(8) : 902-911. [2] Mortele K J, Oliva M R, Ondategui S, et al.Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital[J]. AJR Am J Roentgenol, 2005,184(1) : 31-34. [3] Cochran S T, Bomyea K, Sayre J W.Trends in adverse events after IV administration of contrast media[J].AJR Am J Roentgenol, 2001,176(6) : 1385-1388. [4] Kyung E J, Ryu J H, Kim E Y.Evaluation of adverse reactions to contrast media in the hospital[J].Br J Radiol,2013,86(1032) : 20130418. [5] Pradubpongsa P, Dhana N, Jongjarearnprasert K, et al.Adverse reactions to iodinated contrast media: prevalence, risk factors and outcome-the results of a 3-year period[J]. Asian Pac J Allergy Immunol,2013,31( 4) : 299-306. [6] 罗馨,刘琴,袁思姝,等.钆对比剂外预热的临床应用及效果观察[J]. 放射学实践, 2014, 29(12): 1483-1485. [7] 中华医学会放射学分会对比剂安全使用工作组.碘对比剂使用指南(第2版)[J]. 中华放射学杂志, 2013, 47 (10): 869-872. [8] 王亮亮. 碘造影剂不良反应处理的临床分析[J]. 中国实用医药, 2017, 12(35): 186-187. [9] 陈韵岱,陈纪言,傅国胜,等.碘对比剂血管造影应用相关不良反应中国专家共识[J]. 中国介入心脏病学杂志, 2014, 22(6): 341-348. [10] 牛记军. 碘造影剂不良反应[J]. 山西医药杂志, 2016, 45(6): 648-651. [11] 余敬. 如何预防碘造影剂不良反应及其护理[J]. 医学理论与实践, 2015, 28(17): 2386-2387. |